Cargando…
Tumor-infiltrating CD62L(+)PD-1(-)CD8 T cells retain proliferative potential via Bcl6 expression and replenish effector T cells within the tumor
Tumor antigen–primed CD8 T cells differentiate into effector T cells that kill tumor cells rapidly, whereas durable responses of CD8 T cells are required to cope with long-lasting tumor growth. However, it is not well known how persisting CD8 T cells are generated. In this study, we analyzed CD8 T c...
Autores principales: | Gong, Yu, Suzuki, Toshihiro, Kozono, Haruo, Kubo, Masato, Nakano, Naoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449457/ https://www.ncbi.nlm.nih.gov/pubmed/32845913 http://dx.doi.org/10.1371/journal.pone.0237646 |
Ejemplares similares
-
Replenish the source within: Rescuing tumor-infiltrating lymphocytes by double checkpoint blockade
por: Duraiswamy, Jaikumar, et al.
Publicado: (2013) -
Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer
por: Kang, Chiao-Wen, et al.
Publicado: (2015) -
Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function
por: Dyck, Lydia, et al.
Publicado: (2022) -
mTOR-dependent translation drives tumor infiltrating CD8(+) effector and CD4(+) Treg cells expansion
por: De Ponte Conti, Benedetta, et al.
Publicado: (2021) -
Human breast tumor-infiltrating CD8(+) T cells retain polyfunctionality despite PD-1 expression
por: Egelston, Colt A., et al.
Publicado: (2018)